Benzinga

España
Italia
대한민국
日本
Français
Benzinga Edge
Benzinga Research
Benzinga Pro

  • Get Benzinga Pro
  • Data & APIs
  • Events
  • Premarket
  • Advertise
Contribute
España
Italia
대한민국
日本
Français

Benzinga

  • Premium Services
  • Financial News
    Latest
    Earnings
    Guidance
    Dividends
    M&A
    Buybacks
    Interviews
    Management
    Offerings
    IPOs
    Insider Trades
    Biotech/FDA
    Politics
    Healthcare
    Small-Cap
  • Markets
    Pre-Market
    After Hours
    Movers
    ETFs
    Options
    Cryptocurrency
    Commodities
    Bonds
    Futures
    Mining
    Real Estate
    Volatility
  • Ratings
    Analyst Color
    Downgrades
    Upgrades
    Initiations
    Price Target
  • Investing Ideas
    Trade Ideas
    Long Ideas
    Short Ideas
    Technicals
    Analyst Ratings
    Analyst Color
    Latest Rumors
    Whisper Index
    Stock of the Day
    Best Stocks & ETFs
    Best Penny Stocks
    Best S&P 500 ETFs
    Best Swing Trade Stocks
    Best Blue Chip Stocks
    Best High-Volume Penny Stocks
    Best Small Cap ETFs
    Best Stocks to Day Trade
    Best REITs
  • Money
    Investing
    Cryptocurrency
    Mortgage
    Insurance
    Yield
    Personal Finance
    Forex
    Startup Investing
    Real Estate Investing
    Prop Trading
    Credit Cards
    Stock Brokers
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
Unusual Options Activity Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Screeners
Stock Screener
Top Momentum Stocks
Top Quality Stocks
Top Value Stocks
Top Growth Stocks
Compare Best Stocks
Best Momentum Stocks
Best Quality Stocks
Best Value Stocks
Best Growth Stocks
Connect With Us
facebookinstagramlinkedintwitteryoutubeblueskymastodon
About Benzinga
  • About Us
  • Careers
  • Advertise
  • Contact Us
Market Resources
  • Advanced Stock Screener Tools
  • Options Trading Chain Analysis
  • Comprehensive Earnings Calendar
  • Dividend Investor Calendar and Alerts
  • Economic Calendar and Market Events
  • IPO Calendar and New Listings
  • Market Outlook and Analysis
  • Wall Street Analyst Ratings and Targets
Trading Tools & Education
  • Benzinga Pro Trading Platform
  • Options Trading Strategies and News
  • Stock Market Trading Ideas and Analysis
  • Technical Analysis Charts and Indicators
  • Fundamental Analysis and Valuation
  • Day Trading Guides and Strategies
  • Live Investor Events
  • Pre-market Stock Analysis and News
  • Cryptocurrency Market Analysis and News
Ring the Bell

A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.

  • Terms & Conditions
  • Do Not Sell My Personal Data/Privacy Policy
  • Disclaimer
  • Service Status
  • Sitemap
© 2026 Benzinga | All Rights Reserved
October 18, 2023 1:02 PM 2 min read

Wendy's Fundamentals Do Not Justify Recent Pressure On Shares: Analyst Says Stock Underappreciated

by Nabaparna Bhattacharya Benzinga Editor
Follow
FlipboardIcon version of the Flipboard logo

Wedbush analyst Nick Setyan reiterated an Outperform rating on Wendy's Company (NASDAQ:WEN), lowering the price target to $24 from $26.50.

Setyan views WEN's current valuation as an overly pessimistic assessment of management's ability to navigate towards MSD-HSD annual EBITDA growth and low- to mid-teens annual EPS and FCF/share growth in 2023 and beyond.

The analyst believes the current buy-side Q3 domestic SSS growth expectation of ~2%, if not slightly lower, is overly downbeat. The current Q3 domestic SSS growth estimate is 3.6%.

The analyst remains optimistic that Q4 domestic SSS growth on a 1-year basis will not be below Q3's, given Q3's comp exit rate, MSD menu pricing, and new menu innovation in Q4.

Like the latter half of Q3, Setyan expects the breakfast daypart to be an outsized contributor to comp and an improving transaction trend.

For now, the analyst conservatively lowers the Q4 company-owned SSS growth estimate to 2.5% from 3.0% and the Q4 domestic franchised SSS growth to 3.0% from 3.5%. This implies a geometric comp vs. 2019 in Q4 of 22.1% vs. 19.7% in Q3 and 19.1% in Q2.

Setyan lowered EBITDA estimates but continues to view the high end of $530-540 million '23 guidance as realistic and model 7.2% growth in '24.

For 2024, while beef inflation will remain a headwind, the analyst thinks it will somewhat be offset by favorable chicken and other basket costs, which should render commodity inflation in 2024 manageable. 

Even with lower menu pricing, Setyan expects higher company margins in '24 (favorable mix and lower U.K. headwinds should also contribute). 

The above comes on the heels of 8.4% EBITDA growth in '23.

Price Action: WEN shares are trading higher by 1.49% to $19.10 on the last checked Wednesday.

Market News and Data brought to you by Benzinga APIs

© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

To add Benzinga News as your preferred source on Google, click here.


Posted In:
Analyst ColorEquitiesNewsPrice TargetReiterationMarketsAnalyst RatingsTrading IdeasGeneralBriefsExpert Ideas
WEN Logo
WENThe Wendy's Co
$7.35-0.92%
Overview

Setyan considers the worst-case Q3 SSS growth scenario to be 2.5%, with a more likely outcome in the 3%-3.5% range as trends improved materially as the quarter progressed, and except for the Midwest, all other regions are >3.5%.

WEN Logo
WENThe Wendy's Co
$7.35-0.92%
Overview
Comments
Loading...